UPDATE 1-Redesigned Edwards heart valve shows improvement in study
* Sapien XT, Sapien show similar death, stroke rates at 1 yr * Fewer complications seen with newer XT model after 30 days By Bill Berkrot SAN FRANCISCO, March 10 (Reuters) - A smaller, redesigned version of Edwards Lifesciences' non-invasive heart valve replacement system called Sapien XT performed well and led to fewer complications than the original Sapien, according to data from a clinical trial presented on Sunday. Both versions, known as transcatheter aortic valve replacem
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here